Bottom line
What is MDOBX's expense ratio?
MDOBX's expense ratio is 2.26%, or about $226 a year on every $10,000 invested. That is more expensive than 99% of international stock funds we track (median 0.9%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Apr 30, 2026
MDOBX fee table
| Net expense ratio | 2.26% |
|---|---|
| Gross expense ratio | 3.06% |
| Management fee | 0.9% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 1.16% |
| Fee waiver / reimbursement | 0.8% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
| Redemption fee | -2% |
Source: Fund prospectus fee table, filed Apr 30, 2026
What MDOBX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MDOBX | $329 | $870 | $1,536 | $3,142 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.26% expense ratio costs roughly $112,300 in lost growth, versus about $50,300 for the median international stock fund (0.9%).